Refining Ethical Guidelines for Early Clinical Trials of Pluripotent Stem-Cell-Derived Therapeutics for Parkinson's Disease

Refining Ethical Guidelines for Early Clinical Trials of Pluripotent Stem-Cell-Derived Therapeutics for Parkinson's Disease